DBV Technologies (DBVT) Assets Average (2016 - 2026)

DBV Technologies (DBVT) posted quarterly Assets Average of $244.8 million for Q2 2026, up 152.38% year-on-year from $97.0 million in Q2 2025, and down 2.1% on a QoQ basis from $250.0 million in Q1 2026.

DBV Technologies (DBVT) Assets Average (2016 - 2026) Analysis & Trends

DBV Technologies (DBVT) has reported Assets Average for 10 consecutive years, with $244.8 million the latest figure, recorded in Q2 2026.

  • Quarterly Assets Average rose 152.38% year-over-year to $244.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $244.8 million (up 152.38% YoY) and the FY2025 annual result came in at $149.7 million, up 20.4% from the prior year.
  • Assets Average eased to $244.8 million in Q2 2026 per DBVT's latest filing, from $250.0 million in the prior quarter.
  • Over the last five years, Assets Average for DBVT reached as high as $266.5 million in Q3 2022 and fell as low as $58.1 million in Q1 2025.
  • A 5-year average of $173.8 million and a median of $179.2 million in 2023 frame the typical range for Assets Average.
  • Annual changes were most pronounced in 2025 — Assets Average slumped 64.66% — and 2026, when it surged 330.3%.
  • Year by year, Assets Average stood at $247.3 million in 2022, then fell by 24.64% to $186.4 million in 2023, then sank by 57.42% to $79.4 million in 2024, then surged by 116.87% to $172.1 million in 2025, then surged by 42.24% to $244.8 million in 2026.
  • According to Business Quant data, Assets Average over the past three periods registered $244.8 million, $250.0 million, and $172.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 303.40 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 65.01 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 8.37 Bn
4 NuCana 279.75 Bn 279.75 Bn - 41.64 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 26.06 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 40.71 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 795.91 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.30 Bn
10 DBV Technologies 267.50 Mn 92.60 Mn - 244.80 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 244.80 Mn
Mar 31, 2026 250.05 Mn
Dec 31, 2025 172.10 Mn
Sep 30, 2025 126.96 Mn
Jun 30, 2025 97.00 Mn
Mar 31, 2025 58.11 Mn
Dec 31, 2024 79.36 Mn
Sep 30, 2024 103.62 Mn
Jun 30, 2024 130.04 Mn
Mar 31, 2024 164.44 Mn
Dec 31, 2023 186.38 Mn
Sep 30, 2023 203.65 Mn
Jun 30, 2023 225.22 Mn
Mar 31, 2023 239.72 Mn
Dec 31, 2022 247.32 Mn
Sep 30, 2022 266.55 Mn
Jun 30, 2022 201.28 Mn
Mar 31, 2022 132.15 Mn
Dec 31, 2021 158.82 Mn
Sep 30, 2021 185.75 Mn